ArticleBMC microbiology2026
Decoding nitrogen depletion-induced lipid accumulation in Aurantiochytrium sp. YHPM1 through integrated proteomic and transcriptomic analyses.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Docosahexaenoic acid (DHA) is a high-value omega-3 polyunsaturated fatty acid (PUFA) with critical roles in human health and nutrition, and Aurantiochytrium species have emerged as promising microbial cell factories for sustainable and scalable DHA biosynthesis, achieving yields of up to 43% of total fatty acids. To elucidate the regulatory mechanisms underlying lipid overproduction in this organism, we performed an integrated proteomic and transcriptomic analysis of the high-yield mutant Aurantiochytrium sp. YHPM1 under a two-stage nitrogen depletion strategy, at 48 and 108 h, the strain exhibited a biphasic metabolic response. Initially, β-oxidation and amino-acid catabolism were suppressed. This was followed by enhanced fatty-acid (FA) and triacylglycerol (TAG) biosynthesis. Moreover, key lipid biosynthetic enzymes, including DGAT, DLAT, and GPAT were markedly upregulated at both transcriptomic and proteomic levels, while β-oxidation enzymes, such as ACADM and FOX2 were suppressed. Notably, 8% of transcripts exhibited discordant transcript–protein expression, most prominently at 48 h, suggesting extensive post-transcriptional regulation. Overall, these findings demonstrate a phased metabolic reprogramming strategy in YHPM1 and advance our understanding of post-transcriptional mechanisms governing DHA accumulation, thereby facilitating the industrial-scale production of DHA using Aurantiochytrium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.